June 17 (Reuters) - The U.S. Food and Drug Administration on Tuesday announced that it will issue a new priority review voucher to drug developers to shorten review time from about 10-12 months to one ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

The recall level is reserved for when consuming the product could potentially cause adverse health consequences or death.

The Trump administration is discussing policies that would make it harder and more expensive for pharmaceutical companies to ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products ...

As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech ...

U.S. health officials said that they would urge foodmakers to phase out petroleum-based artificial colors in the nation’s ...

Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...

Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...

The Johns Hopkins-led and NIH funded OUtMATCH study led to the development of Xolair, a groundbreaking drug that reduces the ...